| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Mdivi-1 | CTRPv2 | pan-cancer | AAC | 0.0067 | 0.9 |
| mRNA | RO-3306 | GDSC1000 | pan-cancer | AAC | -0.0061 | 0.9 |
| mRNA | cimetidine | CTRPv2 | pan-cancer | AAC | 0.012 | 0.9 |
| mRNA | BRD-K90370028 | CTRPv2 | pan-cancer | AAC | 0.01 | 0.9 |
| mRNA | BRD-K92856060 | CTRPv2 | pan-cancer | AAC | 0.0062 | 0.9 |
| mRNA | ML083 | CTRPv2 | pan-cancer | AAC | -0.0066 | 0.9 |
| mRNA | SB590885 | GDSC1000 | pan-cancer | AAC | 0.0056 | 0.9 |
| mRNA | Cytarabine | GDSC1000 | pan-cancer | AAC | -0.006 | 0.9 |
| mRNA | BRD-K66453893 | CTRPv2 | pan-cancer | AAC | -0.0052 | 0.9 |
| mRNA | lomeguatrib | CTRPv2 | pan-cancer | AAC | 0.0061 | 0.9 |